Clinical differences exist between the three forms of myotubular myopathy. They differ regarding age at onset, severity ofthe disease, and prognosis, and also regarding some of the clinical characteristics. The autosomal dominant form mostly has a later onset and milder course than the X linked form, and the autosomal recessive form is intermediate in both respects. These differences are, however, quantitative rather than qualitative. Muscle biopsy studies of family members are useful in some cases, and immunohistochemical staining of desmin and vimentin may help distinguish between the X linked and autosomal forms. Determiining the mode of inheritance and prognosis in individual families, especially those with a single male patient, still poses a problem.
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Current molecular genetic results indicate that the gene for the X linked form is located in the proximal Xq28 region. Further molecular genetic studies are needed to examine the existence of genetic heterogeneity in myotubular myopathy and to facilitate diagnosis. The X linked recessive form of myotubular myopathy (XMTM) is well documented (McKusick *310400).1 An autosomal dominant form (McKusick * 160150)1 and an autosomal recessive form (McKusick 255200)' have been described, although to our knowledge only two reports include verified cases of male to male transmission, and we have found no reports of fully examined families with healthy parents of affected children of both sexes.
No clear consensus exists regarding the use of the alternative names myotubular or centronuclear myopathies. Some authors, including one of us (MF), prefer the descriptive term centronuclear myopathy for the autosomal forms.2 Further studies are needed to resolve this pathogenetic debate.
The myotubular or centronuclear myopathies are among the group of rare myopathies called the congenital myopathies. In addition, a form with hypotrophy of type 1 fibres has been described.3 Type 1 hypotrophy is, however, a common feature in the congenital myopathies and this is not likely to be a distinct condition.
No definite morphological differences have been found on histological examination of muscle biopsies between the autosomal and X linked forms. They are all characterised by smallness of muscle fibres and centrally placed myofibre nuclei. The central areas ofthe muscle fibres are devoid ofmyofibrils, with aggregation of mitochondria. This is reflected by the oxidative enzyme reactions showing central density of staining, and, correspondingly, the ATPase reaction showing central lack of staining. The resemblance to fetal myotubes has been thought to reflect an arrest in morphogenesis of the muscle fibres, a hypothesis corroborated by the results of Sarnat,4 who found persistence of desmin and vimentin staining in the myofibres of patients with XMTM. A similar persistence was not found in late onset cases,56 with one exception. 7 The aim of this review is to outline the features of the different forms o.f myotubular myopathy. The basis of the paper is data on families seen by members of the International XMTM consortium and published familial cases. In addition to previous suggestions of immunohistochemical differences between XMTM and the autosomal forms, some differences are suggested in clinical features such as age at onset and severity of the disease. corresponding central aggregation of mitochondria with the oxidative enzyme stains. The proportion of these myotube-like fibres varied widely.
In most of the patients the disease followed a fatal course. The boys died of respiratory or cardiac failure, in some combined with pneumonia, at ages ranging from 3 hours to 3 years (mean 4-8 months). Family histories often included stillbirths and miscarriages. The boy who survived up to the age of 3 years needed mechanical ventilation all his life.
Six boys were alive at ages of 6 months to 27 years (mean 10 years). Although all but one had respiratory difficulties at birth, respiration later became normal in four of the boys, but two still needed mechanical ventilation at the ages of 8 and 10 years, respectively. One was severely disabled and dependent on others for the activities of daily living, being able to move only his hands to use a computer. Four out of five learned to walk although later than normal, and two ofthese later began to use a wheelchair. Three had no significant disability at the ages of 6 months, 5 years, and 7 years, respectively.
In summary, the clinical picture in XMTM is quite consistent, with perinatal onset of severe generalised muscle weakness and hypotonia, often accompanied by ventilatory insufficiency. Nevertheless, care has to be taken in interpreting the mode of inheritance and prognosis in families with a single male patient. In particular, the prognosis in the X linked form is not always poor and survival into adulthood cannot be regarded as proof of autosomal inheritance.
Sarnat49 has shown that muscle biopsies of boys with XMTM show a persistence ofdesmin and vimentin. Recent studies of a family with autosomal dominant inheritance5 and three solitary adult onset male cases6 did not show a similar persistence, whereas one In the 12 families, there were 21 patients with histologically verified diagnoses of MTM. The sex ratio (male:female) was 0-62. This may well reflect an ascertainment bias since families with male sibs affected may not readily be reported as recessive.
In six of the patients, the onset of the disease was in infancy, in seven it was in early childhood, and in a further eight it was between 8 and 30 years.
Clinical features commonly included ophthalmoplegia, ptosis, and facial weakness. Six of the patients were reported to have feeding difficulties, two were floppy at birth, and two had asphyxia at birth. Muscle weakness was often most pronounced proximally, but some showed an additional distal involvement. Electromyography was normal or showed non-specifically abnormal or "myopathic" features.
In three of the families the parents were consanguineous. Muscle biopsy findings were reported in four of the mothers, all of whom had central nuclei. We found only one report of a biopsy in a father. 55 In this family, one son and one daughter were affected and the parents were healthy (although the mother said she had been thin and weak in her youth) with muscle biopsy findings within normal limits. The interpretation of the biopsy findings is, however, somewhat difficult because histochemical staining methods were not used.
No clinically detectable weakness has been reported in the parents, but not all have been examined. Both parents in one family reportedly showed abnormalities on electromyography. 53 The pedigree described by Sher et al46 warrants a few comments. The clinically healthy mother of two affected girls showed central nuclei in her muscle biopsy. No biopsy was done in the father. If the two affected children had been boys, the mode of inheritance would be interpreted as X linked recessive and the biopsy findings as indicative of heterozygosity for the X chromosomal gene. One possibility is that an autosomal dominant gene with variable penetrance is segregating in this family. Another possibility is that the central nuclei are a manifestation of heterozygosity for an autosomal recessive gene, an interpretation difficult to verify in the absence of results of biopsies from both parents in this and other families. Suggestions of such heterozygote manifestations at biopsy of clinically healthy parents have been reported for another congenital myopathy, nemaline myopathy.56 One could also interpret the pathological findings at electromyography in both (clinically healthy) parents and a clinically healthy sib of an affected boy53 as examples of heterozygote manifestations.
All but one of the 21 patients whose diagnoses had been histologically verified were alive at the time of reporting, at ages between 3 and 32 years (mean 18 years). One patient had died from heart failure at the age of 16 years.
In summary, the age at onset is generally later than in the X linked form and earlier than in the autosomal dominant form. The severity of the disease also seems to be intermediate between that in the other two forms.
Comments and conclusions Clinical differences exist between the various forms of MTM. The age at onset, severity of the disease, and prognosis differ, as do some of the clinical characteristics. 
